...
首页> 外文期刊>Journal of Controlled Release: Official Journal of the Controlled Release Society >Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings
【24h】

Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings

机译:由聚(乙烯醇)-接枝-聚(丙交酯-乙交酯)组成的紫杉醇释放膜及其作为可生物降解支架涂层的潜力

获取原文
获取原文并翻译 | 示例
           

摘要

Although substantial progress in catheter and stent design has contributed to the success of percutaneous transluminal angioplasty (PTA) of atherosclerotic disease, the incidence of restenosis caused by in-stent neointimal hyperplasia remains a serious problem. Therefore, stents with a non-degradable polymer coating showing controlled release of active ingredients have become ail attractive option for the site-specific delivery of anti-restenotic agents. Biodegradable coatings using polyesters, namely poly(lactic-co-glycolic acid) (PLGA) and different poly(vinyl alcohol)graft-poly(lactic-co-glycolic acid) (PVA-g-PLGA) as paclitaxel-eluting stent coating materials were investigated here to evaluate their influence on the release kinetic. Whereas PLGA showed sigmoid release behavior, the paclitaxel release from PVA-g-PLGA films was continuous over 40 days without initial drug burst. Wide angle X-ray diffraction confirmed that paclitaxel is dissolved in the polymer matrix. Paclitaxel crystallization can be observed at a drug load of >= 10%. The effect of drug loading oil polymer degradation was Studied in films prepared from PVA(300)-g-PLGA(30) with paclitaxel loadings of 5% and 15% over a time period of 6 weeks. The results suggest a surface-like erosion mechanism in films. A model stent (Jostent peripheral) coated with Parylene N, a poly(p-xylylene) (PPX) derivate, was covered with a second layer of PVA(300)-9-PLGA(15), and PVA(300)-g-PLGA(30) by using airbrush method. Morphology of coated stents, and film integrity after expansion from 3.12 to 5 mm was investigated by scanning electron microscopy (SEM). The devices resisted mechanical stress during stent expansion and merit further investigation under in vivo conditions. (c) 2006 Elsevier B.V. All rights reserved.
机译:尽管导管和支架设计的实质性进展为动脉粥样硬化疾病的经皮腔内血管成形术(PTA)的成功做出了贡献,但支架内新内膜增生引起的再狭窄发生率仍然是一个严重的问题。因此,具有不可降解的聚合物涂层的支架显示出活性成分的受控释放已成为针对特定部位递送抗再狭窄剂的所有有吸引力的选择。使用聚酯的生物可降解涂料,即聚乳酸-乙醇酸(PLGA)和不同的聚乙烯醇接枝-聚乳酸-乙醇酸(PVA-g-PLGA)作为紫杉醇洗脱支架涂层材料在这里进行了研究,以评估它们对释放动力学的影响。 PLGA表现出乙状结肠释放行为,而紫杉醇从PVA-g-PLGA薄膜中释放的紫杉醇在40天内连续释放,而没有最初的药物爆发。广角X射线衍射证实紫杉醇溶解在聚合物基质中。紫杉醇结晶可在> = 10%的载药量下观察到。在由PVA(300)-g-PLGA(30)制成的薄膜中研究了载药量对聚合物油降解的影响,紫杉醇载量为5%和15%,历时6周。结果表明膜中存在类似表面的腐蚀机理。涂覆有聚对二甲苯(PPX)派瑞林N的模型支架(Jostent外围)覆盖有第二层PVA(300)-9-PLGA(15)和PVA(300)-g -PLGA(30)通过使用喷枪方法。通过扫描电子显微镜(SEM)研究了涂层支架的形态以及从3.12到5 mm膨胀后的薄膜完整性。该设备在支架扩张过程中抵抗了机械应力,值得在体内条件下进行进一步研究。 (c)2006 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号